Hostname: page-component-5c6d5d7d68-sv6ng Total loading time: 0 Render date: 2024-08-27T20:21:47.482Z Has data issue: false hasContentIssue false

Cognitive impairment assessment in schizophrenia. purposely a case

Published online by Cambridge University Press:  27 August 2024

N. Ogando Portilla*
Affiliation:
1Psychiatry, Hospital Universitario Infanta Sofía, Madrid
S. M. Bañón González
Affiliation:
1Psychiatry, Hospital Universitario Infanta Sofía, Madrid
B. Gamo Bravo
Affiliation:
1Psychiatry, Hospital Universitario Infanta Sofía, Madrid
M. E. González Laynez
Affiliation:
2Psychiatry, Hospital universitario de Toledo, Toledo
M. A. Urbanos
Affiliation:
3Psychiatry, Hospital Universitario La Princesa, Madrid
M. M. Cortés
Affiliation:
4Psychiatry, Hospital General Universitario de Alicante Dr Balmis, Alicante, Spain
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Significant and measurable cognitive symptoms are present at the onset of the disorder and these remain stable in the subsequent period between 2 and 5 years. Their deterioration increases with the course of the disease. Attention, concentration, psychomotor speed and resolution of conceptual tasks are usually affected and are more significant in the presence of positive symptoms.

Objectives

Sometimes, the typical positive or negative symptoms of the disease do not adequately reflect the severity of cognitive impairment. Measuring this deterioration can be very relevant when evaluating the severity and the prognosis of the disorder.

Methods

31-year-old male with a previous diagnosis of schizophrenia of 4 years of evolution. He gets a maintained treatment with amisulpiride 400mg with an apparent good response. A single hospitalization at the onset of the disease. An assassination attempt on his mother is done by suffocation with a pillow and observing a significant cognitive impairment despite an apparent control of the symptoms of schizophrenia.

Results

An exhaustive neuropsychological evaluation is carried out, observing a very important cognitive deterioration that had not been previously detected and allowing a pharmacological adjustment of the underlying disease with global improvement of the patient.

Conclusions

It is very important to evaluate the patient as a whole without forgetting the frequent cognitive damage that these patients can have. An intense neuropsychological study can be very useful to evaluate the prognosis and adequate treatment of the patient in order to reduce serious risks.

Disclosure of Interest

None Declared

Type
Abstract
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2024. Published by Cambridge University Press on behalf of European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.